EUVIMEDEUVIMED entdecken
Systematische ÜbersichtOpen Access · CC BY-NC-ND 4.0

SAEM GRACE : Phenobarbital for alcohol withdrawal management in the emergency department: A systematic review of direct evidence

Kiran Punia, William Scott, Kriti Manuja, Kaitryn Campbell, Iris M Balodis, James MacKillop iD

Academic Emergency Medicine · 2024-05 · 31 (5) · 481-492

DOI: 10.1111/acem.14788 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Academic Emergency Medicine, online erschienen am 02.09.2023. Verfasst von Kiran Punia und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychology, Neuroscience, and Behaviour, McMaster University, Ontario, Hamilton, Canada. Hauptthemen laut MEDLINE: Phenobarbital, Emergency Service, Hospital, Substance Withdrawal Syndrome. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Canada Research Chairs, Society for Academic Emergency Medicine.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

Alcohol withdrawal syndrome (AWS) is a commonly presenting condition in the emergency department (ED) and can have severe complications, including mortality. Benzodiazepines are first‐line medications for treating AWS but may be unavailable or insufficient. This systematic review evaluates the direct evidence assessing the utility of phenobarbital for treating AWS in the ED.

Methods

A systematic search was conducted and designed according to the patient–intervention–comparator–outcome (PICO) question: (P) adults (≥18 years old) presenting to the ED with alcohol withdrawal; (I) phenobarbital (including adjunctive); (C) benzodiazepines or no intervention; and (O) AWS complications, admission to a monitored setting, control of symptoms, adverse effects, and adjunctive medications. Two reviewers independently assessed articles for inclusion and conducted risk of bias assessments for included studies.

Results

From 70 potentially relevant articles, seven studies met inclusion criteria: three retrospective cohort studies, two retrospective chart reviews, and two randomized controlled trials (RCTs), one examining phenobarbital monotherapy and one examining adjunctive phenobarbital. Across the retrospective cohort studies, treatment of AWS with phenobarbital resulted in lower odds of a subsequent ED visit. The retrospective chart reviews indicated that phenobarbital was associated with higher discharge rate compared to benzodiazepine‐only treatments. For the two RCTs, phenobarbital did not differ significantly from benzodiazepine for most outcomes, although concomitant treatment with phenobarbital was associated with lower benzodiazepine use and intensive care unit admission. The heterogeneous designs and small number of studies prevented quantitative synthesis.

Conclusions

Relatively few studies provide direct evidence on the utility of phenobarbital for AWS in the ED, but the evidence that exists generally suggests that it is a reasonable and appropriate approach. Additional RCTs and other methodologically rigorous investigations are needed for more definitive direct evidence.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PhenobarbitalEmergency Service, HospitalSubstance Withdrawal SyndromeHumansBenzodiazepinesHypnotics and SedativesMaleAdultFemale

Stichwörter der Autor:innen

alcohol withdrawalalcohol withdrawal syndromeemergency departmentphenobarbitalurgent care

Substanzen

PhenobarbitalBenzodiazepinesHypnotics and Sedatives

Autor:innen und Institutionen

  • Department of Psychology, Neuroscience, and Behaviour, McMaster University, Ontario, Hamilton, Canada.
  • Peter Boris Centre for Addictions Research, St. Joseph's Healthcare Hamilton/McMaster University, Hamilton, Ontario, Canada.
  • Michael G. DeGroote School of Medicine, McMaster University, Hamilton, Ontario, Canada.
  • St. Joseph's Healthcare Hamilton, Hamilton, Ontario, Canada.
  • Department of Psychiatry and Behavioural Neurosciences, McMaster University, Hamilton, Ontario, Canada.
  • Michael G. DeGroote Centre for Medicinal Cannabis Research (CMCR), McMaster University, Hamilton, Ontario, Canada.

ORCID-Profile: James MacKillop

Förderung

  • Canada Research Chairs
  • Society for Academic Emergency Medicine

Zitieren

APA

Punia, K., Scott, W., Manuja, K., Campbell, K., Balodis, I. M., & MacKillop, J. (2024). SAEM GRACE : Phenobarbital for alcohol withdrawal management in the emergency department: A systematic review of direct evidence. Academic Emergency Medicine, 31(5), 481-492. https://doi.org/10.1111/acem.14788

Vancouver

Punia K, Scott W, Manuja K, Campbell K, Balodis IM, MacKillop J. SAEM GRACE : Phenobarbital for alcohol withdrawal management in the emergency department: A systematic review of direct evidence. Academic Emergency Medicine. 2024;31(5):481-492. doi:10.1111/acem.14788

BibTeX
@article{Punia2024,
  author = {Punia, Kiran and Scott, William and Manuja, Kriti and Campbell, Kaitryn and Balodis, Iris M and MacKillop, James},
  title = {SAEM GRACE : Phenobarbital for alcohol withdrawal management in the emergency department: A systematic review of direct evidence},
  journal = {Academic Emergency Medicine},
  year = {2024},
  volume = {31},
  number = {5},
  pages = {481--492},
  doi = {10.1111/acem.14788}
}
Kostenlos starten →